Intrapleural Administration of Cisplatin and Etoposide to Treat Malignant Pleural Effusions in Patients with Non-Small Cell Lung Cancer

Publisher： Karger

E-ISSN： 1421-9794|45|3|197-204

ISSN： 0009-3157

Source： Chemotherapy, Vol.45, Iss.3, 1999-04, pp. : 197-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Schedule-Dependent Synergistic Effect of Pemetrexed Combined with Gemcitabine against Malignant Pleural Mesothelioma and Non-Small Cell Lung Cancer Cell Lines

By  

Chemotherapy, Vol. 54, Iss. 3, 2008-06 ,pp. : 166-175

Karger

Access to resources Recommend Favorite

Phase II Trial of Biweekly Chemotherapy with Docetaxel and Cisplatin in High-Risk Patients with Unresectable Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 3, 2013-10 ,pp. : 159-166

Karger

Access to resources Recommend Favorite

Proteomic Analysis Identified DJ-1 as a Cisplatin Resistant Marker in Non-Small Cell Lung Cancer

By Zeng Hua-Zong   Qu Yi-Qing   Zhang Wen-Jun   Xiu Bing   Deng An-Mei   Liang Ai-Bin  

International Journal of Molecular Sciences, Vol. 12, Iss. 6, 2011-06 ,pp. : 3489-3499

MDPI

Access to resources Recommend Favorite

Malignant Cardiac Tamponade from Non-Small Cell Lung Cancer: Case Series from the Era of Molecular Targeted Therapy

By Li Bob T.   Pearson Antonia   Pavlakis Nick   Bell David   Lee Adrian   Chan David   Harden Michael   Mathur Manu   Marshman David   Brady Peter   Clarke Stephen  

Journal of Clinical Medicine, Vol. 4, Iss. 1, 2014-12 ,pp. : 75-84

MDPI

Access to resources Recommend Favorite

A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung Cancer

By  

Chemotherapy, Vol. 59, Iss. 1, 2013-04 ,pp. : 8-13

Karger

Access to resources Recommend Favorite